Ionis to present at upcoming investor conferences

CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 10, 2026-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

• UBS Global Biopharma Conference on Monday, November 16, 2026

• Jefferies Global Healthcare Conference on Wednesday, November 18, 2026

• Citi’s 2026 Global Healthcare Conference on Tuesday, December 1, 2026

• Piper Sandler 38th Annual Healthcare Conference on Wednesday, December 2, 2026

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261110915887/en/

Source: Ionis Pharmaceuticals, Inc.